Pro-Life Groups Urge Trump to Block Mail Delivery of Abortion Pills
In Washington, numerous pro-life organizations are appealing to President Trump to intervene and prevent the Food and Drug Administration (FDA) from allowing abortion pills to be sent through the mail. They believe that the Justice Department could resolve this issue by addressing an ongoing lawsuit.
A legal challenge from Louisiana against a Biden administration policy allowing the mail delivery of mifepristone, a key drug in abortion procedures, is currently in process at the Fifth Circuit Court of Appeals in New Orleans.
In 2021, the Biden FDA removed the requirement for patients to have an in-person consultation to receive abortion pills, formalizing this change in 2023.
The Trump administration’s FDA has upheld this policy for now, although it has begun a safety review, with preliminary findings expected as soon as next month.
Louisiana contends that the FDA’s decision to drop the in-person dispensing requirement has enabled abortion providers to bypass the state’s strict regulations on the procedure.
Recently, the Supreme Court blocked a Fifth Circuit ruling that had imposed temporary in-person dispensing of mifepristone.
Just last week, the Department of Justice filed a complaint supporting the idea of maintaining mail-in regulations while the legal proceedings unfold.
In a letter addressed to Acting Attorney General Todd Blanche, Susan B. Anthony Pro-Life America, along with 83 other anti-abortion groups, stated, “Agreeing to the court-ordered consent decree would terminate the Biden administration’s unlawful mail-order abortion drug policy and reinstate in-person dispensing while the FDA conducts a swift and thorough safety review.”
The letter further emphasized, “Each month the Justice Department prolongs this process, abusers continue to possess dangerous means for coercion, state laws get undermined, unborn lives are lost, and women face avoidable dangers.” They urged a settlement in the Louisiana v. FDA case to end the legal defense of the mail-order abortion pill program.
Pro-life advocates have been critical of the eased requirements regarding access to mifepristone, which blocks specific hormones necessary for sustaining pregnancy. Typically, a medical abortion is carried out using mifepristone alongside misoprostol, the latter of which helps expel the contents of the uterus.
Mifepristone is also utilized to manage miscarriages and treat conditions like Cushing’s syndrome.
Approximately two-thirds of abortions in the United States are attributed to medical methods, according to the Guttmacher Institute.
Former FDA Commissioner Martin McCulley, who resigned in May, faced criticism from pro-life activists and Republican figures for being slow on mifepristone’s safety assessment.
Since the 2022 Supreme Court ruling in Dobbs v. Jackson Women’s Health Organization, abortion rights groups have been advocating for the use of mail-order mifepristone as a means for women to circumvent restrictive laws in conservative states.
The Justice Department has not yet commented on this situation.
